Personalised cancer care: promises and challenges of targeted therapy.
作者信息
Tu Shi-Ming, Bilen Mehmet A, Tannir Nizar M
机构信息
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA.
出版信息
J R Soc Med. 2016 Mar;109(3):98-105. doi: 10.1177/0141076816631154. Epub 2016 Mar 1.
Abstract
摘要
相似文献
1
Personalised cancer care: promises and challenges of targeted therapy.个性化癌症护理：靶向治疗的前景与挑战
J R Soc Med. 2016 Mar;109(3):98-105. doi: 10.1177/0141076816631154. Epub 2016 Mar 1.
2
A decade of promises in personalised cancer medicine: is the honeymoon over?个性化癌症医学十年之承诺：蜜月期结束了吗？
Med J Aust. 2014 Feb 17;200(3):132-3. doi: 10.5694/mja14.00018.
3
The Promise and the Hype of 'Personalised Medicine'.“个性化医疗”的前景与炒作
New Bioeth. 2017 Apr;23(1):13-20. doi: 10.1080/20502877.2017.1314886.
4
UK’s adopts systematic approach to personalised cancer medicine.英国采用系统方法推进个性化癌症医疗。
Mol Oncol. 2011 Jun;5(3):217-9. doi: 10.1016/j.molonc.2011.04.002.
5
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).当今及未来肿瘤学中的精准医疗——个性化癌症医疗的前景与挑战：欧洲医学肿瘤学会（ESMO）立场文件
Ann Oncol. 2014 Sep;25(9):1673-1678. doi: 10.1093/annonc/mdu217. Epub 2014 Jun 20.
6
A new year and a bright hope for personalised medicine, but what about the quality of cancer patient care?新的一年，个性化医疗充满光明希望，但癌症患者的护理质量又如何呢？
Eur J Cancer Care (Engl). 2013 Jan;22(1):1-2. doi: 10.1111/ecc.12034.
7
Patient-reported outcomes and personalised cancer care.患者报告的结局与个性化癌症护理。
Med J Aust. 2021 May;214(9):406-408.e1. doi: 10.5694/mja2.50893. Epub 2020 Dec 13.
8
Personalised cancer care in the era of precision medicine.精准医学时代的个体化癌症护理。
Aust J Gen Pract. 2021 Aug;50(8):533-537. doi: 10.31128/AJGP-04-21-5953.
9
Personalised cancer follow-up: risk stratification, needs assessment or both?个性化癌症随访：风险分层、需求评估还是两者兼顾？
Br J Cancer. 2012 Apr 24;106(9):1579-80. doi: 10.1038/bjc.2012.108.
10
From Rosalind Franklin to Barack Obama: Data Sharing Challenges and Solutions in Genomics and Personalised Medicine.从罗莎琳德·富兰克林到巴拉克·奥巴马：基因组学与个性化医疗中的数据共享挑战与解决方案
New Bioeth. 2017 Apr;23(1):64-73. doi: 10.1080/20502877.2017.1314883.
引用本文的文献
1
An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.一种用于预测胰腺导管腺癌辅助化疗反应的与急救医疗技术员相关的基因特征
Front Cell Dev Biol. 2021 Apr 30;9:665161. doi: 10.3389/fcell.2021.665161. eCollection 2021.
2
Leveraging TCGA gene expression data to build predictive models for cancer drug response.利用 TCGA 基因表达数据构建癌症药物反应的预测模型。
BMC Bioinformatics. 2020 Sep 30;21(Suppl 14):364. doi: 10.1186/s12859-020-03690-4.
3
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.放射性碘治疗后的分化型甲状腺癌采用仑伐替尼和索拉非尼治疗：系统评价和经济评估。
Health Technol Assess. 2020 Jan;24(2):1-180. doi: 10.3310/hta24020.
4
The Adaptive Complexity of Cancer.癌症的适应性复杂性。
Biomed Res Int. 2018 Dec 5;2018:5837235. doi: 10.1155/2018/5837235. eCollection 2018.
5
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.机器学习可以高精度地预测个体癌症患者对治疗药物的反应。
Sci Rep. 2018 Nov 6;8(1):16444. doi: 10.1038/s41598-018-34753-5.
6
A Charter to Improve Patient Care in Severe Asthma.改善重症哮喘患者护理宪章。
Adv Ther. 2018 Oct;35(10):1485-1496. doi: 10.1007/s12325-018-0777-y. Epub 2018 Sep 4.
7
Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations.结直肠癌诊断与治疗中的个性化医疗：卫生经济评估的系统综述
Cost Eff Resour Alloc. 2018 Jan 22;16:2. doi: 10.1186/s12962-018-0085-z. eCollection 2018.
8
Recent developments in the management of germ cell tumors.生殖细胞肿瘤管理的最新进展。
Curr Opin Oncol. 2017 May;29(3):172-178. doi: 10.1097/CCO.0000000000000361.
本文引用的文献
1
The scientific method: pillar and pitfall of cancer research.科学方法：癌症研究的支柱与陷阱
Cancer Med. 2014 Aug;3(4):1035-7. doi: 10.1002/cam4.248. Epub 2014 Apr 8.
2
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.表观基因组改变定义了致命的 CIMP 阳性婴儿室管膜瘤。
Nature. 2014 Feb 27;506(7489):445-50. doi: 10.1038/nature13108. Epub 2014 Feb 19.
3
Stem cell origin of testicular seminoma.睾丸精原细胞瘤的干细胞起源。
Clin Genitourin Cancer. 2013 Dec;11(4):489-94. doi: 10.1016/j.clgc.2013.04.015. Epub 2013 Jul 10.
4
Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.重新审视生殖细胞肿瘤中的DNA损伤修复、p53介导的细胞凋亡和顺铂敏感性。
Int J Dev Biol. 2013;57(2-4):273-80. doi: 10.1387/ijdb.130135mb.
5
Cancer: a "stem-cell" disease?癌症：一种“干细胞”疾病？
Cancer Cell Int. 2013 May 6;13(1):40. doi: 10.1186/1475-2867-13-40.
6
Breast cancer stem cells: we've got them surrounded.乳腺癌干细胞：我们已经包围了它们。
Clin Cancer Res. 2013 Feb 1;19(3):511-3. doi: 10.1158/1078-0432.CCR-12-3450. Epub 2012 Dec 18.
7
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer.可变克隆性再增殖动力学影响结直肠癌的化疗反应。
Science. 2013 Feb 1;339(6119):543-8. doi: 10.1126/science.1227670. Epub 2012 Dec 13.
8
Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell.支持体瘤样恶性肿瘤和畸胎瘤起源于同一祖细胞的分子遗传学证据。
Am J Surg Pathol. 2012 Dec;36(12):1849-56. doi: 10.1097/PAS.0b013e31826df1ab.
9
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
10
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.结直肠癌中针对 EGFR 阻断的获得性耐药的分子进化。
Nature. 2012 Jun 28;486(7404):537-40. doi: 10.1038/nature11219.
Zotero 插件